Important matters:
China Financial Development (03623): Proposed acquisition of GNW Capital Limited's 45% shareholding increase to 96%
Kuaishou-W (01024): National Artificial Intelligence Fund strategically invested 1.4 billion yuan in Beijing Keling
Xinyi Glass (00868) plans to split the automotive glass business and list independently on the main board of the Stock Exchange
Minglue Technology-W (02718) subsidiary plans to acquire 11.33% of Wuhan Nightingale's shares
Shiyao Group (01093): Phase I clinical trial of SYH2092 injection for weight management in adult overweight or obese patients officially launched at the first research center in China
Jinghe Integration (02249) plans to increase capital to Anhui Ruijing Semiconductor with 100% of its shares in Hefei Realtek Technology
China Biopharmaceutical (01177) and Cipla signed an exclusive licensing agreement for TQB2102
Shanghai Pharmaceutical (02607): Lucotinib phosphate tablets approved for production
Okanvision Bio-B (01477): OT-202 Phase III Clinical Trial Completed First Patient Enrollment
Shandong Xinhua Pharmaceutical Co., Ltd. (00719): Azithromycin tablets passed generic drug consistency evaluation
True Health Medical-B (02697) signed a sales contract of nearly 100 million yuan for puncture navigation and positioning systems
China Technology Group (01725) and Hi-Chain Digital Technology will develop a strategic cooperation to establish a joint venture to take advantage of the advantages of precision manufacturing smart terminals
Baidu Group-W (09888) announces dual major listing on the main board of the Hong Kong Stock Exchange
Operating performance:
Hard Egg Innovation (00400) released interim results. Profit attributable to shareholders of 279 million yuan increased 111.1% year over year
Zhengli Xinneng (03677) announced interim results. Profit attributable to shareholders of 372 million yuan increased 68.6% year on year, power battery business revenue increased 53.3% year on year
Horizon Robot-W (09660) released interim results with net profit of 3.784 billion yuan, turning a year-on-year loss into profit. The share of its own brand ADAS broke 50% for the first time
Lin Qingxuan (02657) announced interim results, net profit of 256 million yuan, an increase of 40.7% over the previous year
Times Angel (06699) announced interim results. Profit attributable to shareholders of US$27.251,000 increased by 86.1% year-on-year
Zhiyuan Holdings (00990) has excellent interim results: operating profit surged 139%, and the main line of transformation is becoming more and more clear
Jiufang Smart Investment Holdings (09636) 2026 Interim Results Report: Implementing the AI Technology Global Strategy and Establishing a Closed Loop in Investment Services